Cargando…
Apoptosis in cancer: from pathogenesis to treatment
Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis o...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197541/ https://www.ncbi.nlm.nih.gov/pubmed/21943236 http://dx.doi.org/10.1186/1756-9966-30-87 |
_version_ | 1782214323189317632 |
---|---|
author | Wong, Rebecca SY |
author_facet | Wong, Rebecca SY |
author_sort | Wong, Rebecca SY |
collection | PubMed |
description | Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases. In some, the problem is due to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the culprit. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die. The mechanism of apoptosis is complex and involves many pathways. Defects can occur at any point along these pathways, leading to malignant transformation of the affected cells, tumour metastasis and resistance to anticancer drugs. Despite being the cause of problem, apoptosis plays an important role in the treatment of cancer as it is a popular target of many treatment strategies. The abundance of literature suggests that targeting apoptosis in cancer is feasible. However, many troubling questions arise with the use of new drugs or treatment strategies that are designed to enhance apoptosis and critical tests must be passed before they can be used safely in human subjects. |
format | Online Article Text |
id | pubmed-3197541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31975412011-10-21 Apoptosis in cancer: from pathogenesis to treatment Wong, Rebecca SY J Exp Clin Cancer Res Review Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases. In some, the problem is due to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the culprit. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die. The mechanism of apoptosis is complex and involves many pathways. Defects can occur at any point along these pathways, leading to malignant transformation of the affected cells, tumour metastasis and resistance to anticancer drugs. Despite being the cause of problem, apoptosis plays an important role in the treatment of cancer as it is a popular target of many treatment strategies. The abundance of literature suggests that targeting apoptosis in cancer is feasible. However, many troubling questions arise with the use of new drugs or treatment strategies that are designed to enhance apoptosis and critical tests must be passed before they can be used safely in human subjects. BioMed Central 2011-09-26 /pmc/articles/PMC3197541/ /pubmed/21943236 http://dx.doi.org/10.1186/1756-9966-30-87 Text en Copyright ©2011 Wong; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Wong, Rebecca SY Apoptosis in cancer: from pathogenesis to treatment |
title | Apoptosis in cancer: from pathogenesis to treatment |
title_full | Apoptosis in cancer: from pathogenesis to treatment |
title_fullStr | Apoptosis in cancer: from pathogenesis to treatment |
title_full_unstemmed | Apoptosis in cancer: from pathogenesis to treatment |
title_short | Apoptosis in cancer: from pathogenesis to treatment |
title_sort | apoptosis in cancer: from pathogenesis to treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197541/ https://www.ncbi.nlm.nih.gov/pubmed/21943236 http://dx.doi.org/10.1186/1756-9966-30-87 |
work_keys_str_mv | AT wongrebeccasy apoptosisincancerfrompathogenesistotreatment |